Damien Gruson
Professor Damien Gruson is Head of the Department of Clinical Biochemistry at the Cliniques Universitaires Saint-Luc in Brussels. He is also Professor at UCLouvain, where he is affiliated with the research unit in Endocrinology, Diabetes, and Nutrition.
He currently serves as President-Elect of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and as Chair of the Division on Emerging Technologies of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). His leadership focuses on innovation in laboratory medicine, including point-of-care testing, digital health, artificial intelligence, and preventive diagnostics.
Professor Gruson is a board member of the Royal Belgian Society of Laboratory Medicine and of the Belgian Thyroid Club. He is a Fellow of the European Society of Cardiology, the Heart Failure Association, and the ADLM Academy.
Aiheet
A Smarter Laboratory: How Automation, Clinical Decision Support and AI Shape Our Future
At the celebration of 50 years of Labquality Days I open two windows. The first window gives a sight on how we came where we are. There has been an enormous progress during the fifty years in the use of laboratory data information. The improvement of the quality of this information is based on four pillars: Harmonisation of the profession based on the EFLM Academy (previously EC4 Register), Harmonisation of the training based on the EFLM Syllabus for post-graduate training Harmonisation of quality of laboratories based on accreditation according to the ISO standard for medical laboratories which we established (ISO 15189) Harmonisation of laboratory data via External Quality Assessment and commutable materials as in the Calibration 2000 project The four pillars are shortly discussed. Focus is on the fourth pillar, EQA The second window gives a view on the present and the future of quality in medical laboratories. What should we focus on and how can we do that. Who should be involved? Laboratory information is increasingly important in medical care. Think of topics like auto immune diseases, liquid biopsy, and personalised medicine. Quality of laboratory data and information remains the issue to hold on. It is time to use big data in IQA and EQA as in patient based QC set up better EQA for POCT set up evaluation and EQA for home tests involve medical doctors for their input in defining outcome based analytical performance specifications involve the patient, show how we can help in medical care and ask their needs.